Literature DB >> 19482865

Prominent brainstem and cerebellar involvement in multiple sclerosis with psoriasis.

G Ganesvaran1, J M Greer, M P Pender.   

Abstract

INTRODUCTION: We identified a subgroup of 20 patients with multiple sclerosis (MS) and psoriasis within a total group of 692 patients with MS.
RESULTS: There was a high (80%) incidence of brainstem and/or cerebellar involvement and a high mean (+/-SD) Multiple Sclerosis Severity Score (6.06 +/- 2.88) in this subgroup. Of the patients who were human leukocyte antigen typed, 53% carried the MS-associated allele, DRB1*1501, and 27% carried the psoriasis-associated DRB1*07 allele.
CONCLUSION: The high incidence of brainstem and cerebellar involvement might be explained by the greater severity of MS and the high frequency (60%) of carriage of DRB1*04, DRB1*07, and/or DRB1*13 alleles, which are associated with brainstem and cerebellar involvement in MS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482865     DOI: 10.1177/1352458509103612

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  5 in total

1.  Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis.

Authors:  Michaela Andelova; Karolina Vodehnalova; Jan Krasensky; Eliska Hardubejova; Tereza Hrnciarova; Barbora Srpova; Tomas Uher; Ingrid Menkyova; Dominika Stastna; Lucie Friedova; Jiri Motyl; Jana Lizrova Preiningerova; Eva Kubala Havrdova; Bénédicte Maréchal; Mário João Fartaria; Tobias Kober; Dana Horakova; Manuela Vaneckova
Journal:  BMC Neurol       Date:  2022-07-19       Impact factor: 2.903

2.  Psoriasis during natalizumab treatment for multiple sclerosis.

Authors:  Jorge Millán-Pascual; Laura Turpín-Fenoll; Pablo Del Saz-Saucedo; Ignacio Rueda-Medina; Santiago Navarro-Muñoz
Journal:  J Neurol       Date:  2012-10-25       Impact factor: 4.849

3.  Psoriasis during interferon beta treatment for multiple sclerosis.

Authors:  Loredana La Mantia; F Capsoni
Journal:  Neurol Sci       Date:  2009-11-19       Impact factor: 3.307

4.  Reactivity to Novel Autoantigens in Patients with Coexisting Central Nervous System Demyelinating Disease and Autoimmune Thyroid Disease.

Authors:  Judith M Greer; Simon Broadley; Michael P Pender
Journal:  Front Immunol       Date:  2017-05-08       Impact factor: 7.561

5.  Alemtuzumab-related thyroid disease in people with multiple sclerosis is associated with age and brainstem phenotype at disease onset.

Authors:  Siew Mei Yap; Mary Dillon; Rachel K Crowley; Christopher McGuigan
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-06-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.